Cargando…

Do we need new prokinetics to reduce enteral feeding intolerance during critical illness?

Gastrointestinal feeding intolerance and critical illness-associated gastric motility dysfunction are common. Although recent guidelines recommend not interrupting gastric feeding when gastric residual volume (GRV) is lower than 500 mL or to completely abandon measurement of GRV, it may seem that th...

Descripción completa

Detalles Bibliográficos
Autor principal:	van Zanten, Arthur Raymond Hubert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035451/ https://www.ncbi.nlm.nih.gov/pubmed/27663648 http://dx.doi.org/10.1186/s13054-016-1466-3

Ejemplares similares

Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients
por: Vijayaraghavan, Rajan, et al.
Publicado: (2021)

Should we stop prescribing metoclopramide as a prokinetic drug in critically ill patients?
por: van der Meer, Y Gert, et al.
Publicado: (2014)

Prediction of prokinetic agents in critically ill patients with feeding intolerance: a prospective observational clinical study
por: Lv, Guangxuan, et al.
Publicado: (2023)

Identification of risk factors for enteral feeding intolerance screening in critically ill patients
por: Xu, Lei, et al.
Publicado: (2017)

Impact of Erythromycin as a Prokinetic on the Gut Microbiome in Children with Feeding Intolerance—A Pilot Study †
por: Thavamani, Aravind, et al.
Publicado: (2023)

How to improve worldwide early enteral nutrition performance in intensive care units?
por: van Zanten, Arthur Raymond Hubert
Publicado: (2018)

Mounting Clarity on Enteral Feeding in Critically Ill Patients
por: Morrissette, Katelin M., et al.
Publicado: (2020)

Predicting enteral feeding intolerance in patients with sepsis: Why and how?
por: Arabi, Yaseen M.
Publicado: (2022)

Nasogastric feeding intolerance in the critically ill
por: OConnor, S, et al.
Publicado: (2011)

Response to Gunst and Casaer on the letter to the editor “Is the protein intake saturated at doses recommended by the feeding guidelines for critically ill patients?”
por: van Zanten, Arthur Raymond Hubert
Publicado: (2018)

Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
por: Cheng, Yisong, et al.
Publicado: (2021)

Erythromycin or metoclopramide for feed intolerance in the critically ill
por: Nguyen, N, et al.
Publicado: (2006)

Prokinetic agents in critical care
por: Doherty, Warren L, et al.
Publicado: (2003)

Real-time continuous glucose monitoring in children with critical illness - do we need it?
por: El-Nawawy, Ahmed
Publicado: (2015)

Management of hypocalcaemia in the critically ill
por: Melchers, Max, et al.
Publicado: (2023)

Feeding intolerance in critically ill patients with COVID-19
por: Liu, Rebecca, et al.
Publicado: (2022)

The efficacy and safety of prokinetics in critically ill adults receiving gastric feeding tubes: A systematic review and meta-analysis
por: Peng, Rong, et al.
Publicado: (2021)

The prevalence and possible causes of enteral tube feeding intolerance in critically ill patients: A cross-sectional study
por: Yahyapoor, Farveh, et al.
Publicado: (2021)

Do we need to reduce surgical smoke?
por: Stewart, Camille L.
Publicado: (2022)

The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials
por: Lewis, Kim, et al.
Publicado: (2016)

Do we need to innovate in critical care practice?
por: Blanch, Lluis, et al.
Publicado: (2013)

Prevalence and Risk Factors of Enteral Feeding Intolerance in Critically Ill Patients and the Effectiveness of Preventive Treatments: A Prospective Study
por: Xiao, Yajuan, et al.
Publicado: (2023)

Frequency, determinants and impact of feed intolerance amongst the critically ill
por: Gungabissoon, U, et al.
Publicado: (2012)

Intermittent feeding and circadian rhythm in critical illness
por: Kouw, Imre W.K., et al.
Publicado: (2022)

The efficacy and safety of itopride in feeding intolerance of critically ill patients receiving enteral nutrition: a randomized, double-blind study
por: Elmokadem, Eman Mohamed, et al.
Publicado: (2021)

Using Machine-Learning to Assess the Prognostic Value of Early Enteral Feeding Intolerance in Critically Ill Patients: A Retrospective Study
por: Raphaeli, Orit, et al.
Publicado: (2023)

The Effects of Mukbang Watching on Enteral Feeding Intolerance Among Critically Ill Patients: Study Protocol for a Randomized Controlled Trail
por: Yin, Yao, et al.
Publicado: (2023)

Benefit of prokinetics during enteral nutrition: still searching for a piece of evidence
por: Dive, Alain
Publicado: (2016)

Different definitions of feeding intolerance and their associations with outcomes of critically ill adults receiving enteral nutrition: a systematic review and meta-analysis
por: Li, Jianbo, et al.
Publicado: (2023)

Does the evidence show that prokinetic agents are effective in healing esophagitis and improving symptoms of GERD?
por: Looijer-van Langen, Mirjam, et al.
Publicado: (2007)

The Prokinetic Face of Ghrelin
por: Sallam, Hanaa S., et al.
Publicado: (2010)

Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis
por: van Zanten, Arthur R. H., et al.
Publicado: (2015)

Do we need an assessment of the nutrition risk in the critically ill patient?
por: Preiser, Jean-Charles
Publicado: (2012)

Hydrolysed protein enteral nutrition is not superior to polymeric whole protein feeding with regard to gastrointestinal feeding tolerance and feeding adequacy
por: van Zanten, Arthur R. H., et al.
Publicado: (2017)

Insulin Resistance and Homeostatic Model Assessment in Critically Ill: Where do We Stand?
por: Shah, Jignesh N
Publicado: (2021)

Statin Intolerance—We Know Everything, We Know Nothing
por: Banach, Maciej
Publicado: (2022)

Why do we Need Quality Articles, What are we Going to do With?
por: Mueen Ahmed, KK
Publicado: (2011)

Rikkunshito as a Therapeautic Agent for Functional Dyspepsia and its Prokinetic and Non-Prokinetic Effects
por: Inokuchi, Kazumi, et al.
Publicado: (2021)

Do We Serve a Need?
por: Somberg, John
Publicado: (2021)

Syncope—Do We Need AI?
por: Olshansky, Brian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dgubkceepseh1js7d2n2cm4j64